Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (8 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Research and development
10
22
26
35
41
General and administrative
4
11
15
18
18
Total operating expenses
14
32
41
54
58
Loss from operations
-14
-32
-41
-54
-58
Interest income
0
0
0
0
0
Net loss
-14
-32
-41
-53
-58
Accretion of preferred stock
0
0
0
0
0
Net loss applicable to common stockholders
-14
-32
0
0
0
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Mar 3, 2016 n/a
calculated values,
restated on Mar 3, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (27 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Assets
Cash and cash equivalents
21
10
19
34
25
Short-term investments
27
46
82
59
85
Restricted cash
0
0
0
0
0
Prepaid expenses and other current assets
0
1
1
3
1
Total current assets
48
57
102
95
111
Property and equipment, net
1
1
1
3
2
Long-term investments
9
35
22
0
0
Restricted cash
0
0
0
0
0
Other assets
1
0
0
0
0
Total assets
59
93
125
99
113
Liabilities and owners' equity
Accounts payable
2 2273000
2 1848000
3 2760000
3 3216000
4 3942000
Accrued expenses
1 873000
1 551000
4 4327000
6 5519000
6 6098000
Liability classified stock-based compensation awards
0 0
0 0
1 717000
0 469000
0 69000
Total current liabilities
3 3146000
2 2399000
8 7804000
9 9204000
10 10109000
Other liabilities
0 0
0 0
0 0
1 677000
1 516000
Deferred rent
0 74000
0 38000
0 0
0 0
0 0
Liability for shares subject to repurchase
0 36000
0 20000
0 11000
0 2000
0 0
Obligation to issue warrant
0 406000
0 0
0 0
0 0
0 0
Commitments and contingencies ( Note 10 )
0 0
0 0
0 0
0 0
0 0
Temporary Equity, Carrying Amount, Attributable to Parent
68 68141000
0 0
0 0
0 0
0 0
Convertible preferred stock
0 0
0 0
0 0
0 0
0 0
Common stock
0 1000
0 2000
0 3000
0 3000
0 4000
Additional paid-in capital
2 1702000
137 136893000
205 205068000
230 229770000
301 301305000
Accumulated other comprehensive income
0 -2000
0 22000
0 28000
0 11000
0 43000
Accumulated deficit
-14 -14467000
-46 -46451000
-88 -87653000
-141 -141018000
-199 -198883000
Total stockholders' equity
-13 -12766000
90 90466000
117 117446000
89 88766000
102 102469000
Total liabilities and stockholders' equity
59 59037000
93 92923000
125 125261000
99 98649000
113 113094000
Remarks restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (25 items missing)
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15
Net loss
-14
-32
-41
-53
-58
Depreciation and amortization
0
0
0
0
1
Stock-based compensation expense
2
7
10
12
10
Amortization of premiums and discounts on available-for-sale marketable securities
0
0
0
0
0
Non-cash expense related to purchase of technology rights
0
2
0
1
0
Obligation to issue a warrant in exchange for license
0
0
0
0
0
Change in fair value of obligation to issue a warrant
0
0
0
0
0
Loss on disposal of fixed assets
0
0
0
0
0
Prepaid expenses and other current assets
0
0
0
0
0
Accounts payable
2
0
1
0
1
Accrued expenses and other liabilities
0
0
4
2
0
Liability classified stock-based compensation awards
0
0
1
0
0
Net cash used in operating activities
-9
-23
-26
-37
-46
Purchases of property and equipment
-1
0
0
-2
0
Purchases of investments
-36
-154
-118
-39
-200
Maturities of investments
0
108
95
85
173
Increase in restricted cash
0
0
0
0
0
Net cash (used in) provided by investing activities
-37
-46
-23
43
-27
Proceeds from the issuance of redeemable convertible preferred stock
64
0
0
0
0
Proceeds from the exercise of stock options
0
0
0
0
0
Net proceeds from the issuance of common stock and restricted common stock
-1
58
60
10
64
Cash used to settle restricted stock liability awards
0
0
-1
-1
0
Net cash provided by financing activities
63
58
58
9
64
(Decrease) increase in cash and cash equivalents
17
-11
9
15
-9
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Mar 10, 2015 n/a
calculated values,
restated on Mar 3, 2016 n/a
calculated values,
restated on Mar 3, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,